Hazra Rudranil, Ozturk Mumin, Peton Nashied, Ganief Tariq, Poswayo Sibongiseni Kl, Rousseau Robert P, Naidoo Saiyukthi, Jones Shelby-Sara, Savulescu Anca F, Moseki Raymond M, Du Plessis Nelita, Blackburn Jonathan, Mhlanga Musa M, Kahn C Ronald, Brombacher Frank, Wilkinson Robert J, Parihar Suraj P
Wellcome Discovery Research Platforms in Infections, Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Diseases and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town 7925, Republic of South Africa.
Division of Medical Microbiology, Institute of Infectious Diseases and Molecular Medicine (IDM), Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, Republic of South Africa.
bioRxiv. 2025 May 23:2025.05.19.653976. doi: 10.1101/2025.05.19.653976.
A host-modulating candidate gene involved in putative pathogen-killing pathways, with potential novel therapeutic intervention, Protein Kinase C - δ (PKCδ) has been recognized as a critical marker of inflammation with clinical and experimental evidence in recent years. Pulmonary microenvironment during infection is largely governed by lung resident macrophages, initiating innate and subsequent adaptive immune responses. We investigated the role of PKCδ in macrophages using a macrophage-specific PKCδ knockout mice model (LysMPKCδ). PKCδ deficiency in macrophages triggers an early lymphocytic immune response, increases neutrophil recruitment, and reduces inflammatory macrophages in the lungs, leading to higher burden and exacerbated pathology. Experimental and omics analysis further revealed that dysregulation of antimicrobial effector functions is detrimental to macrophage's ability to restrict bacterial growth . Importantly this defect was mitigated by exogenous GM-CSF supplementation and/or overexpressing PKCδ in macrophages. Thus, PKCδ plays a crucial role in immune modulation during infection with GM-CSF amongst several downstream pathways through which PKCδ exerts its regulatory effects.
蛋白激酶C-δ(PKCδ)是一种参与假定病原体杀伤途径的宿主调节候选基因,具有潜在的新型治疗干预作用,近年来,临床和实验证据已将其确认为炎症的关键标志物。感染期间的肺部微环境很大程度上由肺驻留巨噬细胞控制,启动先天性和随后的适应性免疫反应。我们使用巨噬细胞特异性PKCδ基因敲除小鼠模型(LysMPKCδ)研究了PKCδ在巨噬细胞中的作用。巨噬细胞中PKCδ的缺乏会引发早期淋巴细胞免疫反应,增加中性粒细胞募集,并减少肺部的炎性巨噬细胞,导致更高的负担和更严重的病理状况。实验和组学分析进一步表明,抗菌效应功能的失调不利于巨噬细胞限制细菌生长的能力。重要的是,通过外源性补充GM-CSF和/或在巨噬细胞中过表达PKCδ,这种缺陷得到了缓解。因此,PKCδ在感染期间的免疫调节中起着关键作用,GM-CSF是PKCδ发挥其调节作用的几个下游途径之一。